- Report
- April 2026
Middle East, Africa
From €3196EUR$3,450USD£2,667GBP
€1611EUR$1,800USD£1,299GBP
€1859EUR$2,077USD£1,499GBP
€1611EUR$1,800USD£1,299GBP
€1859EUR$2,077USD£1,499GBP
- Report
- March 2026
- 109 Pages
Europe
From €3659EUR$3,950USD£3,053GBP
- Report
- March 2026
- 103 Pages
Asia Pacific
From €3659EUR$3,950USD£3,053GBP
- Report
- March 2026
- 83 Pages
Africa, Middle East
From €3196EUR$3,450USD£2,667GBP
- Report
- March 2026
- 92 Pages
North America
From €3196EUR$3,450USD£2,667GBP
- Report
- January 2026
- 75 Pages
Africa, Middle East
From €3196EUR$3,450USD£2,667GBP
- Report
- January 2026
- 88 Pages
Europe
From €3659EUR$3,950USD£3,053GBP
- Report
- January 2026
- 83 Pages
North America
From €3196EUR$3,450USD£2,667GBP
- Report
- January 2026
- 110 Pages
United States
From €1417EUR$1,530USD£1,183GBP
€1667EUR$1,800USD£1,391GBP
- Report
- April 2025
- 285 Pages
Global
From €5395EUR$6,028USD£4,350GBP
- Report
- October 2025
- 300 Pages
Global
From €4445EUR$4,799USD£3,710GBP
- Report
- September 2018
- 200 Pages
Global
From €3241EUR$3,499USD£2,705GBP
- Directory
- January 2026
- 276 Pages
Europe
- Directory
- January 2026
- 381 Pages
Global
- Report
- October 2025
- 578 Pages
Global
From €4585EUR$4,950USD£3,826GBP
- Report
- September 2025
- 289 Pages
Global
From €4585EUR$4,950USD£3,826GBP
- Report
- August 2025
- 522 Pages
Global
From €4585EUR$4,950USD£3,826GBP
- Report
- May 2024
- 362 Pages
Global
From €4585EUR$4,950USD£3,826GBP

The Pharmaceutical Regulation market is a sector of the pharmaceutical industry that focuses on the regulation of drugs and other related products. It is responsible for ensuring that drugs are safe and effective for use by the public. This includes the evaluation of clinical trials, the approval of new drugs, and the monitoring of drug safety and efficacy. The market also includes the enforcement of regulations and the enforcement of intellectual property rights.
The Pharmaceutical Regulation market is composed of a variety of stakeholders, including pharmaceutical companies, regulatory authorities, and research institutions. Pharmaceutical companies are responsible for the development and production of drugs, while regulatory authorities are responsible for the approval and monitoring of drugs. Research institutions are responsible for conducting clinical trials and providing data to regulatory authorities.
Some of the major companies in the Pharmaceutical Regulation market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Show Less Read more